Use of Integrative Therapies During and After Breast Cancer Treatment
Recommendations
- Use of music therapy, meditation, stress management and yoga for anxiety/stress reduction.
- Use of meditation, relaxation, yoga, massage and music therapy for depression/mood disorders.
- Use of meditation and yoga to improve quality of life.
- Use of acupressure and acupuncture for reducing CINV.
- There is a lack of strong evidence supporting the use of ingested dietary supplements or botanical agents as supportive care and/or to manage breast cancer treatment‐related side effects.
Recommendation Grading
Overview
Title
Use of Integrative Therapies During and After Breast Cancer Treatment
Authoring Organization
Society for Integrative Oncology
Publication Month/Year
April 24, 2017
Last Updated Month/Year
April 2, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
This report provides updated clinical practice guidelines from the Society for Integrative Oncology on the use of integrative therapies for specific clinical indications during and after breast cancer treatment, including anxiety/stress, depression/mood disorders, fatigue, quality of life/physical functioning, chemotherapy‐induced nausea and vomiting, lymphedema, chemotherapy‐induced peripheral neuropathy, pain, and sleep disturbance.
Inclusion Criteria
Female, Adult, Older adult
Health Care Settings
Ambulatory, Hospital, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Counseling, Management
Diseases/Conditions (MeSH)
D003863 - Depression, D001943 - Breast Neoplasms, D001007 - Anxiety
Keywords
breast cancer, depression, anxiety, sleep disorders, Breast Cancer
Source Citation
Greenlee, H., DuPont‐Reyes, M.J., Balneaves, L.G., Carlson, L.E., Cohen, M.R., Deng, G., Johnson, J.A., Mumber, M., Seely, D., Zick, S.M., Boyce, L.M. and Tripathy, D. (2017), Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment. CA: A Cancer Journal for Clinicians, 67: 194-232. doi:10.3322/caac.21397